Merck & Co., Inc. is 8.7x more valuable than Zoetis Inc. by market capitalization ($294.13 B vs $33.79 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ZTS | MRK |
|---|---|---|
| Market cap | $33.79 B | $294.13 B |
| US-listed rank | #427 | #44 |
| Revenue (latest FY) | $9.47B | $65.01B |
| Net income (latest FY) | $2.67B | $18.25B |
| Net margin | 28.2% | 28.1% |
| P/E (trailing FY) | 12.6 | 16.1 |
| SEC filings | 2,040 | 996 |
Merck & Co., Inc. is 8.7x more valuable than Zoetis Inc. by market capitalization ($294.13 B vs $33.79 B).
In their latest fiscal years, Zoetis Inc. reported $9.47B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Zoetis Inc. and Merck & Co., Inc., or browse the full rankings.